Feeling sick?

Use the Symptom Checker to check your symptoms

Add this to your profile
Banner for leaf pages 2

Sevelamer (Renvela)

Also known as Renagel and Renvela


Sevelamer (rINN) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. It is marketed by Genzyme (now Sanofi-Aventis) under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate).

Source: Wikipedia

Estimated Total Cost: $453.29 for an average of 28 days supply

What is it prescribed for?

Patients are most commonly prescribed sevelamer to treat kidney failure, kidney disease due to longstanding hypertension, chronic ulcer, and chronic kidney disease.

Ajax-loader Loading...